Merrimack Pharmaceuticals Aktie

8,45 -2,87% -0,25 €
08:00 Uhr Frankfurt | Orderbuch | Mehr Kurse »
WKN: A2DW3Q
ISIN: US5903282094
US-Symbol: MACK
Typ: Aktie

Performance Merrimack Pharmaceuticals Aktie

1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 10,46 $ 10,35 $ 13,26 $ 10,25 $ 30,50 $ 108,70 $
Änderung -0,76% +0,29% -21,72% +1,27% -65,97% -90,45%

Forum zur Merrimack Pharmaceuticals Aktie

RichyBerlin: MACK auf der JPMorgan
05.01.18
"..to present at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018, at 9:00 a.m. PT in San Francisco.." http://www.ariva.de/news/merrimack-​to-present-at-the-36th-​annual-j-p-morgan-6710644
biotech1x1: News vom 24.03.2016
30.03.16
Merrimack Announces Inclusion of ONIVYDE® (irinotecan liposome injection) as a Category 1 Treatment Option in the 2016 NCCN Guidelines for Pancreatic Adenocarcinoma https://beta.finance.yahoo.com/news/merrimack-​announces-inclusion-onivyde-irinotecan-...

Analysen

Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

Aktie & Unternehmen

Branche Pharmazeutik
Herkunft USA
Website www.merrimack.com
Aktienanzahl 13,3 Mio. (Stand: 11.09.17)
Marktkap. 112,2 Mio. €

Dividenden & Splits

06.09.17 Reverse Split 10:1
30.05.17 Dividende   10,00 EUR

Ähnliche Aktien

Name
last
change_rel
 
Neothetics 1,59 € +2,58%
Editas Medicine 24,80 € +0,81%
KalVista Pharmaceuticals 8,10 € -1,22%
Rocket Pharmaceuticals 9,622 € +0,76%
PLx Pharma 5,10 € 0,00%